Abbott Laboratories (NYSE:ABT)
| 104.52 Delayed Data As of Dec 08 |  +0.47 / +0.45%Today’s Change | 89.67 Today|||52-Week Range 115.83 | -4.80% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 20.4B | 20.9B | 27.4B | 30.6B | |
| Cost of Goods Sold | 8.0B | 8.3B | 11.2B | 11.5B | ||
| Depreciation And Amortization | 1.5B | 1.4B | 3.0B | 3.3B | ||
| Operating Expenses | Gross Income | 11.0B | 11.2B | 13.1B | 15.8B | |
| General Expenses | 8.0B | 8.0B | 11.0B | 12.0B | ||
| Research And Development | 1.4B | 1.4B | 2.1B | 2.3B | ||
| Total Operating Expenses | 17.5B | 17.6B | 25.3B | 26.7B | ||
| Non-Operating Expenses | Operating Income | 2.9B | 3.2B | 2.1B | 3.8B | |
| Extraordinary Credit | 79.0M | -- | -- | -- | ||
| Extraordinary Charge | -206.0M | -112.0M | -362.0M | -247.0M | ||
| Interest Expense On Debt | 193.0M | 326.0M | 907.0M | 729.0M | ||
| Other Expenses | 434.0M | -1.5B | 1.2B | -100.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 3.2B | 1.4B | 2.2B | 2.9B | |
| Income Taxes | -577.0M | -350.0M | -1.9B | -539.0M | ||
| Discontinued Operations | 65.0M | 321.0M | 124.0M | 34.0M | ||
| Extraordinary Items | 1.8B | 16.0M | 0.00 | 0.00 | ||
| Net Income | 2.7B | 1.4B | 468.0M | 2.4B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.5B | 1.5B | 1.7B | 1.8B | |
| Shares To Calculate EPS Diluted | 1.5B | 1.5B | 1.7B | 1.8B | ||
| Earnings Per Share | EPS | $2.92 | $0.94 | $0.27 | $1.33 | |
| EPS Diluted | $1.76 | $0.93 | $0.27 | $1.33 | ||
